Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Luteolin & Non-Alcoholic Fatty Liver Disease (NAFLD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Luteolin inhibited the TLR4 signaling pathway in the liver, thereby reducing the secretion of pro-inflammatory factors and alleviating NAFLD
Liu et al. 2021s Archives of Biochemistry and Biophysics 711: 109019

16S rRNA gene sequencing revealed that Luteolin intervention significantly altered the gut microbiota composition in NAFLD rats and increased gut microbiota richness
Liu et al. 2021s Archives of Biochemistry and Biophysics 711: 109019

Luteolin alleviates [NAFLD](brain://vgmzB9ARjk2g76rB…

References (Sources)

Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis
Liu et al. 2021s Archives of Biochemistry and Biophysics 711: 109019

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Luteolin & Non-Alcoholic Fatty Liver Disease (NAFLD)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat